Varcodes 8 mg and Ugurol 500 mg

This image features two distinct pharmaceutical products commonly found in the Italian healthcare market. The first is Varcodes 8 mg, an effervescent corticosteroid containing Dexamethasone. It is produced and marketed by Epionpharma, an Italian pharmaceutical company founded in Italy that focuses on specialized therapeutic areas like onco-hematology and respiratory health.

The second product is Ugurol 500 mg, an antifibrinolytic medication containing Tranexamic Acid, used to prevent or treat bleeding. Ugurol is a brand currently owned by Viatris, a global healthcare giant formed in November 2020 through the merger of Mylan and Pfizer's Upjohn division. While the brand has historical roots in Europe, it is now part of the Viatris global portfolio, which operates manufacturing facilities in numerous countries including Italy, France, Germany, and India. Viatris is headquartered in the United States and is a publicly traded company on the NASDAQ.